Literature DB >> 31434818

Comprehensive research on thyroid diseases associated with autoimmunity: autoimmune thyroid diseases, thyroid diseases during immune-checkpoint inhibitors therapy, and immunoglobulin-G4-associated thyroid diseases.

Hidefumi Inaba1, Hiroyuki Ariyasu1, Ken Takeshima1, Hiroshi Iwakura1, Takashi Akamizu1.   

Abstract

Various thyroid diseases are associated with autoimmunity. Major autoimmune thyroid diseases are Graves' disease (GD) and Hashimoto's thyroiditis (HT). Thyrotropin receptor is an autoantigen in GD, and its immunogenicity has been examined. Immune-checkpoint inhibitor (ICI) is recently widely used for treatment of malignant tumors, but cases of thyroid diseases during ICI treatment have been increasing. Thyroid diseases during ICI therapy have been investigated in immunological and clinical aspects, and their Japanese official diagnostic guidelines were established. In addition, serum and tissue immunoglobulin-G4 levels have been examined in association with clinicopathological characteristics in GD, HT, and Riedel's thyroiditis. We review these diseases associated with thyroid autoimmunity and comprehensively discuss their potential application in future research and therapeutic options.

Entities:  

Keywords:  Graves’ disease; Hashimoto’s thyroiditis; Immune-checkpoint inhibitors; Immunoglobulin G4; Riedel’s thyroiditis

Mesh:

Substances:

Year:  2019        PMID: 31434818     DOI: 10.1507/endocrj.EJ19-0234

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  4 in total

1.  Safety and efficacy of CAR T cells in a patient with lymphoma and a coexisting autoimmune neuropathy.

Authors:  Khushali S Jhaveri; Ilana Schlam; Noa G Holtzman; Monica Peravali; Perry K Richardson; Saurabh Dahiya; Vera Malkovska; Aaron P Rapoport
Journal:  Blood Adv       Date:  2020-12-08

2.  Human Leukocyte Antigens and Biomarkers in Type 1 Diabetes Mellitus Induced by Immune-Checkpoint Inhibitors.

Authors:  Hidefumi Inaba; Yosuke Kaido; Saya Ito; Tomonao Hirobata; Gen Inoue; Takakazu Sugita; Yuki Yamamoto; Masatoshi Jinnin; Hiroaki Kimura; Tomoko Kobayashi; Shintaro Iwama; Hiroshi Arima; Takaaki Matsuoka
Journal:  Endocrinol Metab (Seoul)       Date:  2022-02-28

Review 3.  Thyroid-related adverse events induced by immune checkpoint inhibitors.

Authors:  Alexandra Chera; Andreea Lucia Stancu; Octavian Bucur
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-20       Impact factor: 6.055

4.  Predictive and sensitive biomarkers for thyroid dysfunctions during treatment with immune-checkpoint inhibitors.

Authors:  Chiaki Kurimoto; Hidefumi Inaba; Hiroyuki Ariyasu; Hiroshi Iwakura; Yoko Ueda; Shinsuke Uraki; Ken Takeshima; Yasushi Furukawa; Shuhei Morita; Yuki Yamamoto; Shimpei Yamashita; Masahiro Katsuda; Atsushi Hayata; Hiroaki Akamatsu; Masatoshi Jinnin; Isao Hara; Hiroki Yamaue; Takashi Akamizu
Journal:  Cancer Sci       Date:  2020-03-17       Impact factor: 6.716

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.